Diagnostic review can be planned as a separate episode
When NMOSD is uncertain or was previously labeled as MS, the center may review imaging, repeat antibody testing and extend CSF or differential-diagnostic work-up. Ask which tests are included in the estimate and whether outside MRI can be reviewed remotely before travel.
- Neuroimmunology specialist consultation
- AQP4-IgG testing
- MOG-IgG testing when clinically indicated
- Brain, orbital and spinal-cord MRI as required
- CSF examination when indicated
- Neuro-ophthalmology or electrophysiological testing in selected cases
Acute relapse treatment is not the same as elective medical travel
A severe relapse can require urgent intravenous high-dose corticosteroids, apheresis and inpatient neurological monitoring. The cost of an acute attack depends on severity, number of treatment days, imaging, rescue therapy and rehabilitation needs. Sudden visual or neurological deterioration should be treated locally first rather than delayed for a planned foreign-hospital quotation.
Apheresis creates its own hospital cost pathway
When plasma exchange or another blood-wash procedure is required, the estimate can include vascular access, repeated treatment sessions, laboratory monitoring and inpatient or day-unit resources. Ask for a course-specific quotation rather than assuming apheresis is included in a routine relapse package.
Long-term relapse prevention can dominate the ongoing budget
Preventive immunotherapy may be continued for years and can involve high-cost biologic or other immunosuppressive treatment plus laboratory and infection monitoring. The first German consultation is therefore only one part of the total treatment cost. Clarify whether ongoing therapy can be prescribed and administered in the patient's home country.
Monitoring and MRI should be included in long-term planning
Heidelberg describes regular laboratory and neurological follow-up with repeat MRI at intervals. Ask which blood tests, specialist visits and imaging are expected during the first year and which can be performed locally.
The diagnosis itself can materially change the cost plan
NMOSD, MOGAD and MS do not have interchangeable long-term treatment strategies. Paying for a generic 'demyelinating disease package' before diagnostic clarification can lead to an inaccurate estimate. The quotation should be linked to the final specialist diagnosis and treatment goal.
Send complete records before requesting an estimate
The center can plan more accurately when the attack history and diagnostic evidence are available before travel.
- Neurology reports and relapse timeline
- AQP4-IgG and MOG-IgG results
- MRI images and reports
- CSF results
- Visual testing for optic neuritis
- Previous steroid and apheresis treatment
- Current and previous preventive immunotherapy
- The purpose of the inquiry: diagnosis review, post-relapse review or long-term treatment planning
Official sources
Last source-reviewed 2026-09-01. Cost procedures and published service fees can change, so confirm current terms directly with the provider before transferring money or booking travel.